Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

Johannes J Voegel

  • Home
  • Johannes J Voegel

Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs

Posted by By BCDSP May 8, 2013Posted inUncategorized
Journal: The Journal of Investigative Dermatology Authors: Julia Spoendlin 1, Johannes J Voegel 2, Susan S Jick 3, Christoph R Meier 4 NLM Citation: Spoendlin J, Voegel JJ, Jick SS, Meier CR. Risk of rosacea in patients…
Read More

Spironolactone may reduce the risk of incident rosacea

Posted by By BCDSP April 17, 2013Posted inUncategorized
Journal: The Journal of Investigative Dermatology Authors: Julia Spoendlin 1, Johannes J Voegel 2, Susan S Jick 3, Christoph R Meier 4 NLM Citation: Spoendlin J, Voegel JJ, Jick SS, Meier CR. Spironolactone may reduce the risk…
Read More
  • @BCDSP_DRG on Twitter
Boston Collaborative Drug Surveillance Program

11 Muzzey Street | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
Fax: +1 (781) 862-1680
E-mail: bcdsp@bcdsp.org

Copyright 2024 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top